echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Luye Pharma and Yuli Pharmaceutical reached a cooperation agreement

    Luye Pharma and Yuli Pharmaceutical reached a cooperation agreement

    • Last Update: 2021-08-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On August 2, Luye Pharma’s official website indicated that it will reach a cooperation agreement with Yuli Pharmaceutical to grant Yuli Pharmaceutical the central nervous system drug Seroquel (Quetiapine Fumarate, immediate release) and Seroquel Sustained Release Tablets (sustained release) Preparations) exclusive distribution rights in Malaysia and Brunei


    Public information shows that Seroquel and its sustained-release tablets are atypical antipsychotics with antidepressant properties, used to treat schizophrenia and bipolar disorder


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.